This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Crawford & Company B (CRD.B) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Crawford & Company B (CRD.B) delivered earnings and revenue surprises of 64.71% and 4.84%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
SPS Commerce (SPSC) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
SPS Commerce (SPSC) delivered earnings and revenue surprises of 17.54% and 1.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Viad (VVI) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Viad (VVI) delivered earnings and revenue surprises of -9.92% and 10.03%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Viad, Bowman Consulting Group and BGSF
by Zacks Equity Research
Viad, Bowman Consulting Group and BGSF are part of the Zacks Industry Outlook article.
3 Business Services Stocks Benefiting From a Prospering Industry
by Zacks Equity Research
With rising demand and growing technology adoption, the Zacks Business Services industry is poised to prosper. VVI, BWMN and BGSF are three stocks set to ride this demand strength.
WNS or VVI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
WNS vs. VVI: Which Stock Is the Better Value Option?
WNS vs. VVI: Which Stock Is the Better Value Option?
by Zacks Equity Research
WNS vs. VVI: Which Stock Is the Better Value Option?
Viad (VVI) Q3 Earnings Miss Estimates
by Zacks Equity Research
Viad (VVI) delivered earnings and revenue surprises of -34.80% and 11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights WNS (Holdings), BGSF and Viad
by Zacks Equity Research
WNS (Holdings), BGSF and Viad are part of the Zacks Industry Outlook article.
3 Top Business Services Stocks Braving Industry Challenges
by Zacks Equity Research
With manufacturing and service activities remaining healthy, the Zacks Business Services industry is poised to prosper. WNS, BGSF and VVI are three stocks set to ride this demand strength.
BGSF vs. VVI: Which Stock Is the Better Value Option?
by Zacks Equity Research
BGSF vs. VVI: Which Stock Is the Better Value Option?
4 Stocks to Buy on Steady Growth in Services Sector Activity
by Ritujay Ghosh
Services activity has been growing despite surging prices, helping stocks like ZipRecruiter (ZIP), Viad Corp (VVI), Cross Country Healthcare (CCRN) and GEE Group (JOB).
Viad (VVI) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Viad (VVI) delivered earnings and revenue surprises of 3,800% and 21.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
WNS vs. VVI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
WNS vs. VVI: Which Stock Is the Better Value Option?
APG vs. VVI: Which Stock Is the Better Value Option?
by Zacks Equity Research
APG vs. VVI: Which Stock Is the Better Value Option?
Viad (VVI) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Viad (VVI) delivered earnings and revenue surprises of -25.66% and 10.21%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Viad (VVI): Can Its 12.2% Jump Turn into More Strength?
by Zacks Equity Research
Viad (VVI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Viad (VVI) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Viad (VVI) delivered earnings and revenue surprises of -36.78% and 20.12%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Services (HCSG) Q4 Earnings Miss Estimates
by Zacks Equity Research
Healthcare Services (HCSG) delivered earnings and revenue surprises of -76.92% and 0.34%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Viad (VVI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Viad (VVI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Viad (VVI) Q3 Earnings Miss Estimates
by Zacks Equity Research
Viad (VVI) delivered earnings and revenue surprises of -66.86% and 55.46%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Viad (VVI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Viad (VVI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: TPI Composites, Cameco Corp, Hexcel Corp and Viad Corp
by Zacks Equity Research
Zacks.com featured highlights include: TPI Composites, Cameco Corp, Hexcel Corp and Viad Corp
4 Toxic Stocks That Don't Deserve a Place in Your Portfolio
by Rimmi Singhi
Investors who can correctly spot the overpriced toxic stocks and shun them at the right time are the ones likely to make a profit.
Viad (VVI) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Viad (VVI) delivered earnings and revenue surprises of -145.45% and 17.31%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?